Global type 1 diabetes burden remains high despite advances

The past few years have seen numerous advances in the understanding of how type 1 diabetes develops and how to manage it, yet the global disease burden remains high, according to a review article published April 5 in The Lancet.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup